| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a489959a65f15e020ae35952c1e7aff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e02eee919a3fb7960a2f90f7c6d26f08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ea792ca13ee47367f9dcf38eedda6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf2df450ae470ce09c5ef978fc5fd05f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17f3d0b49e7ace6f767106ad1b721951 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2007-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cc75c30ca133f65db648173c5be4f1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5be16272c3e5cda199d3ff8e132fe37c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dbb012ae743d939d9858d35447d8929
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c11873f4fd75a2cfc9186f42ed9d300 |
| publicationDate |
2013-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8460883-B2 |
| titleOfInvention |
Activation epitope of FcγRII (CD32), binding molecules that specifically bind the epitope and means and methods for the detection of the epitope, and uses of said epitope or said binding molecules |
| abstract |
The present invention provides means and method for detecting an activation epitope on FcyRII (CD32) on Fcγ (CD32) expressing cells. The presence of epitope on FcγRII (CD32) correlates with priming of the cell containing FcγRII (CD32) expressing said epitope. The invention further provides binding molecules specific for said activation epitope on FcγRII (CD32), and uses thereof in the detection of activated cells. Further uses are the treatment of individuals suffering from inflammation or at risk of suffering thereof. Also provided, among others, are uses for detecting and/or following an inflammation in an individual. |
| priorityDate |
2006-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |